M
Martina Gropp-Meier
Researcher at Ludwig Maximilian University of Munich
Publications - 19
Citations - 1524
Martina Gropp-Meier is an academic researcher from Ludwig Maximilian University of Munich. The author has contributed to research in topics: Medicine & Lymphadenectomy. The author has an hindex of 6, co-authored 13 publications receiving 959 citations.
Papers
More filters
Journal ArticleDOI
Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial
Eric Pujade-Lauraine,Jonathan A. Ledermann,Frédéric Selle,Val Gebski,Richard T Penson,Amit M. Oza,Jacob Korach,Tomasz Huzarski,Andres Poveda,Sandro Pignata,Michael Friedlander,Nicoletta Colombo,Philipp Harter,Keiichi Fujiwara,Isabelle Ray-Coquard,Susana Banerjee,Joyce F. Liu,Elizabeth S. Lowe,Ralph Bloomfield,Patricia Pautier,Tomasz Byrski,Giovanni Scambia,Maria Ornella Nicoletto,Fiona Nussey,Andrew R Clamp,Richard T. Penson,Amit M. Oza,Andrés Poveda Velasco,Manuel Rodrigues,Jean-Pierre Lotz,Diane Provencher,Aleix Prat Aparicio,Laura Vidal Boixader,Clare L. Scott,Kenji Tamura,Mayu Yunokawa,Alla Lisyanskaya,Jacques Medioni,Nicolas Pécuchet,Coraline Dubot,Thibault De La Motte Rouge,Marie-Christine Kaminsky,Béatrice Weber,Alain Lortholary,Christine Parkinson,Jonathan A. Ledermann,Sarah Williams,Jonathan Cosin,James Hoffman,Marie Plante,Allan Covens,Gabe S. Sonke,Florence Joly,Anne Floquet,H. Hirte,Amnon Amit,Tjoung-Won Park-Simon,Koji Matsumoto,Sergei Tjulandin,Jae Hoon Kim,Jae Hoon Kim,Laurence Gladieff,Roberto Sabbatini,David M. O'Malley,Patrick Timmins,Daniel Kredentser,Nuria Laínez Milagro,Maria Pilar Barretina Ginesta,Ariadna Tibau Martorell,Alfonso Gómez de Liaño Lista,Belén Ojeda González,Linda Mileshkin,Masaki Mandai,Ingrid A. Boere,Petronella B. Ottevanger,Joo-Hyun Nam,Elias Abdo Filho,Salima Hamizi,Francesco Cognetti,David Warshal,Elizabeth Dickson-Michelson,Scott Kamelle,Nathalie McKenzie,Gustavo C. Rodriguez,Deborah K. Armstrong,Eva Chalas,Paul Celano,Kian Behbakht,Susan E Davidson,Stephen Welch,Limor Helpman,Ami Fishman,Ilan Bruchim,Magdalena Sikorska,Anna Słowińska,Wojciech Rogowski,Mariusz Bidziński,Beata Śpiewankiewicz,Antonio Casado Herraez,César Mendiola Fernández,Martina Gropp-Meier,Toshiaki Saito,Kazuhiro Takehara,Takayuki Enomoto,Hidemichi Watari,Chel Hun Choi,Byoung-Gie Kim,Jae Weon Kim,Jae Weon Kim,Roberto Hegg,Ignace Vergote +110 more
TL;DR: Olaparib tablet maintenance treatment provided a significant progression-free survival improvement with no detrimental effect on quality of life in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation.
Journal ArticleDOI
Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial
Jacobus Pfisterer,Catherine M Shannon,Klaus Baumann,Joern Rau,Philipp Harter,Florence Joly,Jalid Sehouli,Ulrich Canzler,Barbara Schmalfeldt,Barbara Schmalfeldt,Andrew Dean,Alexander Hein,Alain G. Zeimet,Lars Hanker,Thierry Petit,Frederik Marmé,Ahmed El-Balat,Rosalind Glasspool,Nikolaus de Gregorio,Sven Mahner,Sven Mahner,Tarek M Meniawy,Tjoung-Won Park-Simon,Marie-Ange Mouret-Reynier,Cristina Costan,Werner Meier,Alexander Reinthaller,Jeffrey C Goh,Tifenn Lharidon,Sally Baron Hay,Stefan Kommoss,Andreas du Bois,Jean-Emmanuel Kurtz,Sven Ackermann,Christoph Anthuber,Mustafa Aydogdu,Angelika Baldauf,Wolfgang Bauer,Dirk Behringer,Antje Belau,Alexandra Bender,C Brucker,Alexander Burges,Trygve Daabach,Dominik Denschlag,Mustafa Deryal,Steffen Dörfel,Juliane Ebert,Tanja Fehm,Susanne Maria Feidicker,Gabriele Feisel-Schwickardi,Ricardo Felberbaum,Matthias Frank,Gerhard Gebauer,Bernd Gerber,Axel Gerhardt,Andrea Grafe,Martin Griesshammer,Eva-Maria Grischke,Isolde Gröll,Martina Gropp-Meier,Dietrich Hager,Volker Hanf,Carla Verena Hannig,Peer Hantschmann,Tanja Hauzenberger,Uwe Herwig,Martin Heubner,Carsten Hielscher,Felix Hilpert,Thomas Hitschold,Manfred Hofmann,Christian Jackisch,Wolfgang Janni,Ludwig Kiesel,Yon-Dschun Ko,Hans-Joachim Koch,Petra Krabisch,Peter Krieger,Thomas Kubin,Thorsten Kühn,Björn Lampe,Peter Ledwon,Sabine Lemster,Benno Lex,Clemens Liebrich,Ralf Lorenz,Hans-Joachim Lück,Peter Mallmann,Wolfgang Meinerz,Götz Menke,Volker Möbus,Thomas G. Müller,Volker Müller,Tanja Neunhöffer,Angelika Ober,G. Oskay-Özcelik,Horst Ostertag,Martin Pölcher,Beate Rautenberg,Daniel Rein,Wilhelm Reiter,Andreas Rempen,Ingo B. Runnebaum,Marcus Schmidt,Sabine Schnohr,Heinz Scholz,Willibald Schröder,Eike Simon,Antje Sperfeld,Annette Steckkönig,Hans-Georg Strauß,Ronaldo Stuth,Jürgen Terhaag,Falk Thiel,Marc Thill,Oliver Tomé,Christoph Uleer,Susanne Vogel,Hermann Voß,Michael Weigel,Ulrich Winkler,Arthur Wischnik,Tobias Zeiser,Andreas Zorr,R.M. Glasspool,Emma Hudson,Rachel Jones,Judith Lafleur,Christian Marth,Edgar Petru,Yoland Antill,Mary Azer,Sally Baron-Hay,Philip Beale,Stephen Begbie,Allison Black,Karen Briscoe,Andrew Dean,Jeffrey C. Goh,Sandra Harvey,Chee Lee,Marco Matos,Tarek Meniawy,Inger Olesen,Catherine Shannon,Paul A. Vasey,Sophie Abadie-Lacourtoisie,Olivier Arsene,Sophie Barthier,Célia Becuwe-Roemer,Dominique Berton-Rigaud,Maria Cappiello-Bataller,Stéphanie Catala,Francesco Del Piano,Gael Deplanque,Raymond Despax,Nadine Dohollou,Claire Garnier-Tixidré,Julien Grenier,Emmanuel Guardiola,Anne-Claire Hardy-Bessard,Claudia Lefeuvre-Plesse,Marianne Leheurteur,Anne Lesoin,Charles-Briac Levache,Raffaele Longo,Alain Lortholary,Jérôme Meunier,Nadia Raban,Olivier Romano,Jean-Michel Vannetzel,Alain Zannetti +172 more
TL;DR: This multicentre, open-label, randomised, phase 3 trial was to compare a standard bevacizumab-containing regimen versus carboplatin-pegylated liposomal doxorubicin combined with bevacsumab for progression-free survival in recurrent ovarian cancer.
Journal ArticleDOI
Final results from GCIG/ENGOT/AGO-OVAR 12, a randomised placebo-controlled phase III trial of nintedanib combined with chemotherapy for newly diagnosed advanced ovarian cancer
Isabelle Ray-Coquard,David Cibula,Mansoor Raza Mirza,Alexander Reuss,Caterina Ricci,Nicoletta Colombo,Horst Koch,Frédéric Goffin,Antonio González-Martín,Petronella B. Ottevanger,Klaus Baumann,Line Bjørge,Anne Lesoin,Alexander Burges,Per Rosenberg,Martina Gropp-Meier,Maija Harrela,Philipp Harter,Jean Sébastien Frenel,Tomas Minarik,Carmela Pisano,Annette Hasenburg,Michael Merger,Andreas du Bois +23 more
TL;DR: The previously reported PFS improvement seen with nintedanib did not translate into an OS benefit in the nonhigh‐risk subgroup and subgroup analyses according to stratification factors, clinical characteristics and risk status showed no OS difference between treatments.
Journal ArticleDOI
Randomized phase II trial of carboplatin and paclitaxel with or without lonafarnib in first-line treatment of epithelial ovarian cancer stage IIB-IV.
Werner Meier,Andreas du Bois,Jörn Rau,Martina Gropp-Meier,Klaus Baumann,Jens Huober,K. Wollschlaeger,Rolf Kreienberg,Ulrich Canzler,Barbara Schmalfeldt,Pauline Wimberger,Barbara Richter,W. Schröder,Antje Belau,A. Stähle,Alexander Burges,Jalid Sehouli +16 more
TL;DR: The addition of lonafarnib to standard chemotherapy in first-line treatment of advanced ovarian cancer could improve progression-free (PFS) and overall survival (OS) but did not improve PFS or OS.
Proceedings ArticleDOI
Randomized phase III study to evaluate the impact of secondary cytoreductive surgery in recurrent ovarian cancer – final analysis of AGO DESKTOP III/ENGOT- ov20
P. Harter,Jalid Sehouli,W Meier,Alexander Reuss,Peter Hillemanns,Annette Hasenburg,Felix Hilpert,Dominik Denschlag,Alexander Burges,Lars Hanker,B Lampe,Ulrich Canzler,Martina Gropp-Meier,A. du Bois +13 more